-
Signature
-
/s/ Mark Livingston, Attorney-in-Fact
-
Issuer symbol
-
PGNY
-
Transactions as of
-
02 Mar 2026
-
Net transactions value
-
-$119,007
-
Form type
-
4
-
Filing time
-
04 Mar 2026, 17:31:56 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Swartz Allison |
EVP, GC |
C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK |
/s/ Mark Livingston, Attorney-in-Fact |
04 Mar 2026 |
0001956339 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PGNY |
Common Stock |
Award |
|
+28,409 |
+39% |
$0.000000* |
101,128 |
02 Mar 2026 |
Direct |
F1 |
| transaction |
PGNY |
Common Stock |
Tax liability |
|
-1,551 |
-1.5% |
$17.69* |
99,577 |
02 Mar 2026 |
Direct |
F2 |
| transaction |
PGNY |
Common Stock |
Sale |
$37,977 |
-2,199 |
-2.2% |
$17.27 |
97,378 |
02 Mar 2026 |
Direct |
F3 |
| transaction |
PGNY |
Common Stock |
Tax liability |
|
-2,842 |
-2.9% |
$17.60* |
94,536 |
03 Mar 2026 |
Direct |
F2 |
| transaction |
PGNY |
Common Stock |
Sale |
$8,698 |
-500 |
-0.53% |
$17.40 |
94,036 |
03 Mar 2026 |
Direct |
F3 |
| transaction |
PGNY |
Common Stock |
Sale |
$72,332 |
-4,157 |
-4.4% |
$17.40 |
89,879 |
03 Mar 2026 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PGNY |
Stock Option (Right to Buy) |
Award |
|
+41,430 |
|
$0.000000* |
41,430 |
02 Mar 2026 |
Common Stock |
41,430 |
$17.60 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: